Trial · NCT00853762
Adverse events224
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 224
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site reaction | General disorders | Atacicept 25 mg (With Loading) | 2 | 16 | |
| other | Injection site reaction | General disorders | Atacicept 75 mg (With Loading) | 2 | 17 | |
| other | Injection site reaction | General disorders | Atacicept 150 mg (With Loading) | 5 | 15 | |
| other | Injection site reaction | General disorders | Atacicept 150 mg (Without Loading) | 7 | 22 | |
| other | Fatigue | General disorders | Atacicept 25 mg (With Loading) | 0 | 16 | |
| other | Fatigue | General disorders | Atacicept 75 mg (With Loading) | 2 | 17 | |
| other | Fatigue | General disorders | Atacicept 150 mg (With Loading) | 0 | 15 | |
| other | Fatigue | General disorders | Atacicept 150 mg (Without Loading) | 0 | 22 | |
| other | Nasopharyngitis | Infections and infestations | Atacicept 25 mg (With Loading) | 0 | 16 | |
| other | Nasopharyngitis | Infections and infestations | Atacicept 75 mg (With Loading) | 1 | 17 | |
| other | Nasopharyngitis | Infections and infestations | Atacicept 150 mg (With Loading) | 3 | 15 | |
| other | Nasopharyngitis | Infections and infestations | Atacicept 150 mg (Without Loading) | 2 | 22 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Atacicept 25 mg (With Loading) | 0 | 16 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Atacicept 75 mg (With Loading) | 0 | 17 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Atacicept 150 mg (With Loading) | 2 | 15 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Atacicept 150 mg (Without Loading) | 0 | 22 | |
| other | Injection site pruritus | General disorders | Atacicept 25 mg (With Loading) | 0 | 16 | |
| other | Injection site pruritus | General disorders | Atacicept 75 mg (With Loading) | 1 | 17 | |
| other | Injection site pruritus | General disorders | Atacicept 150 mg (With Loading) | 0 | 15 | |
| other | Injection site pruritus | General disorders | Atacicept 150 mg (Without Loading) | 0 | 22 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00853762/events